LYOPHILIZED PREPARATION OF INFLIXIMAB MONOCLONAL ANTIBODY
Provided is a lyophilized preparation of infliximab monoclonal antibody, including infliximab, a histidine buffer system, a structural protective agent and a surfactant; after reconstitution, concentration of infliximab monoclonal antibody in said preparation is 100-200 mg/ml.
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Provided is a lyophilized preparation of infliximab monoclonal antibody, including infliximab, a histidine buffer system, a structural protective agent and a surfactant; after reconstitution, concentration of infliximab monoclonal antibody in said preparation is 100-200 mg/ml. |
---|